NA indicates not available; Max., maximum; TDI, total dose infusion. Injectafer is marketed outside the United States under the brandname Ferinject.

*DexFerrum Prescribing Information. Shirley, NY: American Regent, Inc, 2010 http://www.americanregent.com/AllProducts.aspx?ProductID=16 Letter and PI.pdf.

^†INFeD Prescribing Information. Morristown, NJ: Watson Pharmaceuticals, Inc, 2010. http://www.infed.com/ information.html.

^‡Ferrlecit Prescribing Information. Bridgewater, NJ: Sanofi-aventis, Inc, 2010. http://products.sanofi-aventis.us/ferrlecit/ferrlecit.html.

^§Venofer Prescribing Information. Shirley, NY: American Regent, Inc, 2010. http://www.venofer.com/pdfs/Venofer%20IN2340%20Rev%2010–08.pdf.

^¶Feraheme Prescribing Information. Lexington, MA: AMAG, Inc, 2010. http://www.feraheme.com/documents/Feraheme%20PI.pdf.

^#Monofer data on file. Holbaek, Denmark: Pharmacosmos A/S, 2010. http://www.pharmacosmos.com/.

**FDA Advisory Committee Briefing Document, Drug Safety and Risk Management Committee, February 1, 2008. http://www.fda.gov/ohrms/dockets/AC/08/briefing/2008–4337b1–01-FDA.pdf. Accessed March 1st., 2010.